Omniscope
Delaware City
About Omniscope
TechBio company decoding the immune system in high resolution to inform therapy and develop diagnostics through the convergence of immune cell sequencing and artificial intelligence. For more information: https://www.omniscope.ai/immune-portal
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.9M
- Funding stage: Private Equity
- Last round: Private Equity (Feb 2025)
- Website: omniscope.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Big Data, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/omniscope-95612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.